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SEROLOGICAL STUDIES OF TRANSPLANTABLE
MOUSE TUMOR 15091a*
HENRY BUNTING
Studies of the histology and growth characteristics of regressing
transplantable tumor 15091a in mice suggested that regression fol-
lowed the acquisition by the host of a specific immunological resist-
ance against the graft.' To test this hypothesis serologically, two
methods of approach have been employed. First, antibodies against
tumor 15091a were sought in (a) mice in which the tumor had
regressed, and (b) mice in which repeated transplants failed to grow.
A subsidiary study was carried out with Sarcoma 37 in an attempt to
confirm Hoyle4 by demonstrating the presence of antibodies against
the sarcoma in mice carrying this tumor. Second, the antigenic
nature of tumor 15091a was studied by (a) testing for antigenic
differences orsimilarities between the tumor and organs from normal
mice, and (b) testing for antigenic differences or similarities between
tumor 15091a and other malignant mouse tumors, e.g., spontaneous
mammary carcinomas and methylcholanthrene-induced sarcomas;
and by (c) fractionating the extract of tumor 15091a to determine
the characteristics of the antigenically active material.
Methods
Tumor 15091a,2 a transplantable mammary carcinoma, arose originally
in an A strain mouse and has been carried in our laboratory in ABC-ALB
mice. Antigens from tumors and normal mouse organs were prepared by
washing small pieces of the tissue (only healthy and non-necrotic tumor tissue
was used) in two or three changes of distilled water after adding formalin to
make a 0.5 per cent solution. Even though sterile precautions were always
taken, chance contamination ruined many antigens until this technic was
adopted. The aqueous suspension was tubed, incubated at 370 C. for from-
4 to 7 hours, and placed at ice-box temperature over night; it was then
centrifuged (2000 r.p.m. for 20 to 30 min.) and the supernatant was tubed
and stored in the ice-box after sufficient concentrated NaCl had been added
to bring it back to normglcy. The concentration of tumor in such an extract
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ranged from 1: 6 to 1: 50 (nitrogen content was 0.2 to 1 per cent); further
dilutions were made at the time of use after determining the anticomplemen-
tary titration as discussed below.
Complement-fixation tests were carried out following the method
described by Zinsser and Bayne-Jones.5 The concentration of antigen used
in the final tests was 3/4 to Y8 of the anticomplementary titer of the antigen.
Sera were inactivated for 10 to 15 minutes at 550 C.; when rabbit anti-mouse
tissue sera were used the heterophile antibodies were absorbed by sheep cells
at ice-box temperature for 30 minutes. As a refinement, in order to insure
the complete mixing of such small amounts* as were available for individual
tests, the usual agglutination tubes were shortened to half-length and arranged
in special racks.
Immunization of rabbits was performed, using the antigen described above,
alone, or with Staphylococcus aureuss toxin as suggested by Dr. G. H. Smith.
The filtrate of an 18-hr. broth culture of strain Wood 46 was used, the
potency of which was such that from 0.01 to 0.1 cc. was fatal for mice;
0.5 cc. of a 1:10 dilution of this toxin was used with the tumor antigen for
immunizing rabbits. No complement-fixing antibodies against staphylococcus
toxin (used in amounts insufficient to produce hemolysis of sheep cells in the
test) were demonstrable in the 15091a antiserum so produced. The rabbits
were usually given 2 series of from 12 to 15 bi-daily intravenous injections
of the tumor antigen or tumor-toxin mixture. Eight days after the last
injection the animals were bled.
Results
I. (a) Complement-fixation tests failed to demonstrate anti-
bodies against tumor 15091a in dba or C Bagg Albino mice in which
the tumor was regressing or had regressed. When the pooled, inac-
tivated sera of two dba mice in which the tumor was regressing was
tested in dilutions as low as 1: 4 there was no complement fixation.
Nor were 15091a antibodies found in inactivated pooled sera (lowest
dilution tested, 1:2) of two dba mice in which the tumor was taking
or in two normal dba mice. Sera of two C Bagg Albino mice in
which transplants of 15091a had regressed 14 and 20 days before,
respectively, were tested individually (a third was tried and found
to be anticomplementary); one gave no reaction in dilutions as low
*The amounts and temperatures used were: antigen 0.1 cc., serum to be tested
0.05 cc., complement (2 units) 0.1 cc., NaCl 0.1 cc.; primary incubation I hr. at 370 C.; hemolytic system amboceptor (2 units) 0.1 cc.; 2%o packed sheep cells
0.1 cc.; secondary incubation of 20 to 30 min. The tubes were then centrifuged
and read.
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as 1: 5 while the other gave complete fixation at 1: 5 and a trace at
1: 10. This is not considered to be of significance, since the serum
of a normal C Bagg Albino mouse had given fixation at a dilution
of 1: 4.
(b) Similarly, sera from two A.BC-ALB mice which had been
completely resistant to 2 and 3 inoculations of tumor 15091a did
not reveal the presence of specific protecting antibodies. The last
transplant had been given about 1 month before bleeding. Pooled
sera from these two mice and from 2 normal ABC-ALB mice were
both negative when tested in dilutions as low as 1: 4.
Hoyle had demonstrated antibodies against Sarcoma 37 (desig-
nated S-37 below) in mice that were carrying this tumor.4 As a
corollary to the above studies we attempted to confirm this finding.
Serum from 1 dba mouse bearing a large S-37 tumor reacted with
S-37 antigen at a dilution of 1: 8, but a normal dba did the same.
The sera of two other S-37-bearingd;ba mice were set up individually
against S-37 antigen but no reaction was found (1: 4 being the lowest
dilution). S-37 is a tumor which becomes necrotic and secondarily
infected very early; it is possible that antigen prepared even from
healthy portions of the tumor included bacterial proteins which sub-
sequently reacted non-specifically with the mouse sera.
II. Studies were undertakento compare theantigenic properties
of tumor 15091a with those of normal mouse organs and of other
malignant mouse tumors, both spontaneous and induced. This was
done by immunizing rabbits against 15091a and comparing the reac-
tions of the antiserum when tested against antigens from these other
sourceswith those obtained with the homologous antigen.
Eight rabbits developed definite titers against 15091a antigen;
3 were immunized by intravenous injections of the tumor antigen
alone, one by intraperitoneal injections of fresh tumor and staphylo-
coccus toxin, and 4 by intravenous tumor antigen and staphylococcus
toxin. In the last group one rabbit developed a titer of 1: 640 with
the homologous antigen and averaged between 1: 80 and 1: 160 at
subsequent bleedings. This serum was used for practically all of
the tests to be described. Two attempted immunizations by intra-
venous injections of tumor antigen alone, and two by intravenous
injection of tumor antigen plus staphylococcus toxin failed to give
rise to specific tumor antibodies. In no normal rabbits have anti-
bodies against 15091a been demonstrated. Heterophile antibodies
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were always found after immunization, even in certain instances in
which the serum contained no complement-fixing antibodies against
15091a antigen. As described above, these were absorbed from the
inactivated serum by sheep cells before use.
(a) Antiserum which reacted with tumor 15091a in titers of
1: 80 and 1: 160 gave no fixation at all with antigens prepared from
the following mouse organs:
Liver-from ABC-ALB strain (repeated tests with 3 preparations of antigen)
Liver-from C3H strain (1 test)
Liver-from dba strain (2 tests on 1 preparation)
Liver-from A-strain (tested 3 preparations)
Kidney-from A-strain (1 test)
Brain-from A-strain (1 test)
Exceptions have been:
Brain-from A-strain (different preparation from that noted above; fixation
in titer equal to that obtained with the homologous antigen)
Liver-from dba strain (fixation to 1: 40 in contrast to 1: 160 noted with
homologous antigen)
Liver-from A-strain (2 out of 4 individual portions of one preparation gave
fixation to 1: 40 in contrast to 1: 80 with the homologous antigen.
The other 2 portions gave no reaction. No explanation for this
inconsistency could be found)
No reaction with serum from dba or C3H mice has been found
with the anti-15091a serum. Washed A-strain red blood cells did
not absorb 15091a antibodies from the anti-15091a serum.
The reciprocal experiment was attempted. In only 2 out of 5
rabbits were antibodies against A-strain liver induced and these were
too feeble (1: 20) for evaluation of results.
(b) In contrast to the above findings is the fixation of comple-
ment by the anti-15091a rabbit serum in the presence of test antigen
prepared from spontaneous mammary carcinorpas from the follow-
ing strains:
C3H-(2 individual tumors, in equal titer to homologous)
ABC-ALB-(1 tumor, in equal titer to homologous)
dba-(2 individual tumors; one reacted in titer equal to that of homologous
antigen, the other to about half of homologous)
C Bagg Albino-(1 tumor in equal titer to homologous)
One antigen from an A-strain carcinoma did not react. One
from a C Bagg Albino strain did not react; in this instance, the
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antigen preparation was probably too dilute, being about 1/10 the
average. It should be mentioned that no reactions were obtained
with antigens prepared from the livers of the individual mice in
which the ABC-ALB and the strongly reacting dba tumor arose.
Tests were made with methylcholanthrene sarcomas; 15091a
antiserum reacted with antigen from a sarcoma induced in a dba and
in an A-strain mouse in equal titer (1: 80-1: 100) to that with the
homologous antigen. Two sarcomas induced in ABC-ALB mice
reacted weakly (1: 20).
Sarcoma 37 antigen did not react with the 15091a antiserum.
When the reciprocal experiment was attempted and 2 rabbits
were injected with antigens prepared from spontaneous mammary
carcinomas that had arisen in C3H and C Bagg Albino mice no anti-
bodies were induced.
(c) Preliminary investigations of the nature of the 15091a
antigen were carried out. Antigen prepared from transplants of
15091a carried for 8 generations in C Bagg Albino mice was in no
way distinguishable from that prepared from tumor grown in the
usual ABC-ALB strain.
The lipoidal nature of the antigen was shown by the following
experiment. The opalescent appearance of 15091a antigen dimin-
ished somewhat after extraction with 2 portions ofethyl ether (15 cc.
each per 20 cc. of antigen) and the antigen no longer reacted with
the antiserum. The ether portions were then evaporated to dry-
ness; the residue was dissolved in 0.5 cc. of cold absolute alcohol
and resuspended drop by drop in 1 cc. of normal NaCl until an
opalescent suspension resulted. This was used as an antigen and
ws found to react to a titer of antiserum of 1: 80 (the original
antigen preparation reacted with antiserum diluted 1: 160).
Antigen was prepared from lyophilized 15091a tissue by ether
and alcohol extraction (in the above manner); the resulting antigen
reacted weakly with the antiserum, 1: 20 to 1: 40, in contrast to
1: 160 of a usual preparation. Extraction of the fresh tumor tissue
by absolute alcohol did not yield an antigen which reacted with
15091a antiserum.
No reaction was obtained with the 15091a antiserum and alco-
holic or cholesterinized Wassermann antigen, showing that the reac-
tions described above were not merely of non-specific nature.
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Conclusions
Earlier histological and growth studies' of regression of trans-
plantable tumor 15091a in mice had suggested that regression fol-
lowed the acquisition of a resistance against the tumor by the host
after implantation.
No circulating complement-fixing antibodies could be demon-
strated against the tumor antigen in sera of mice in which the tumor
had regressed or had failed to grow after 2 or 3 implants.
Using an aqueous extract of tumor 15091a, antibodies were
developed in rabbits which reacted not only with the homologous
antigen, but also with antigens from spontaneous mammary carci-
nomas and methylcholanthrene-induced sarcomas in different strains
of mice. The antiserum, however, did not react with the majority
of antigens prepared from normal mouse liver, kidney, brain, or
mouse sera. Thisis interpreted as indicating a similarity in antigenic
composition between transplantable tumor 15091a and spontaneous
and induced malignant tumors, but a difference between it and
normal mouse tissue. This result is comparable with that obtained
by Dmochowski3 with the Brown-Pearce carcinoma of rabbits and
Murray's liposarcoma of guinea-pigs. In spite of the cross reaction
between the 15091a antisera and spontaneous and induced mouse
tumors, antibodies were not produced when rabbits were injected
with preparations from these other tumors. We similarly had diffi-
culty in inducing specific antibodies against normal mouse liver even
though the heterophile antibody titer became quite high.
The specifically reacting portion of the 15091a antigen was
soluble in ether and alcohol; similar study of the other antigens was
prevented by the premature suspension of this investigation because
of the war effort. Hoyle reported finding a lipoidal antigen in S-37
which, however, was ether insoluble.4 Many others have found
lipoid antigens from tumor tissue (see Hoyle4 for a review of the
subject).
Although we were unable to demonstrate complement-fixing
antibodies against 15091a in the sera of mice in which it had
regressed, and thus failed to confirm our earlier impression, based
on indirect evidence, that regression of transplantable tumor 15091a
followed the acquisition of a specific immunological resistance by the
host, we were able to show that this tumor was antigenically dif-
ferent from normal mouse organs, irrespective of strain. It was
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similar, however, to spontaneous mammary carcinomas and to
methylcholanthrene-induced sarcomas, again irrespective of strain of
origin. The specifically reacting substance in 15091a antigen was
lipoidal in nature, being soluble in ether and absolute alcohol.
Whether the cross reaction of rabbit anti-15091a serum with other
malignant tumors is merely a reflection of the high lipoidal content
that tumor tissue is known to possess or is something more specific is
not yet known.
Summary
1. No complement-fixing antibodies for tumor 15091a were
demonstrable in sera of mice in which the tumor had failed to grow
or had regressed after transplantation.
2. Rabbit anti-15091a serum reacted strongly with heterolo-
gous antigen from five spontaneous mammary carcinomas and two
methylcholanthrene-induced sarcomas, irrespective of the strain of
mice in which they arose; it reacted less strongly with one sponta-
neous carcinoma and two other induced sarcomas. No reaction was
obtained with two other spontaneous mammary carcinomas.
3. Rabbit anti-15091a serum did not react with most of the
antigens of various mouse organs tried-liver, kidney, brain, or
normal mouse serum; exceptional reactions were obtained once with
brain and twice with liver.
4. The specific antigenic substance in extracts of tumor 15091a
was lipoidal, being soluble in ether and alcohol.
5. The results indicate an antigenic dissimilarity between
malignant mouse tumor tissue and normal mouse organs.
REFERENCES
1 Bunting, Henry: Studies of regression in a transplantable tumor in mice. Yale
J. Biol. & Med., 1941, 13, 513-22.
2 Cloudman, A. M.: A comparative study of transplantability of eight mammary
gland tumors arising in inbred mice. Am. J. Cancer, 1932, 16, 568.
3 Dmochowski, L.: Sur la specificite serologique des neoplasmes des animaux de
la tumeur de Brown-Pearce du lapin. Compt. rend. Soc. de biol., 1938,
129, 349.
4 Hoyle, L.: A lipoidal antigen produced by certain malignant tumors of the mouse.
Am. J. Cancer, 1940, 39, 224-33.
5 Zinsser, Hans, and Bayne-Jones, Stanhope: A Textbook of Bacteriology, New
York, 7th ed., 1935, pp. 112-20.
Acknowledgment is made of the valuable technical assistance of Miss Mildred
Goldfaden.